Breakthrough in precision medicine for the treatment of acute myeloid leukemia
Researchers at Karolinska Institutet, among others, have studied the benefit of adding an established drug as a novel targeted therapy in the treatment of acute myeloid leukemia (AML). The results suggest that the drug hydroxyurea ...
Aug 10, 2022
0
5